Why Most Diagnostic Startups Struggle After FDA Approval

Gaining FDA clearance is a critical milestone, but it’s just the beginning.
Many diagnostic startups fail post-approval because they lack a clear commercialization strategy that aligns with market demand and payer expectations.

Read more
/by